European Journal of Molecular & Clinical Medicine

Abstract

Objective: The present study aims at detecting the concentration of human PD-1 in
samples taken from hepatitis C virus patients related to the healthy control group which
studying the relation between viral load associated with (PD-1) concentration.
subject of the treatment group content from 68 samples which is selected randomly
from the patients with HCV, subdivide into 32 males and 36 females aged 23-76 years
with 30 healthy individuals divided 20 males and 10 females. During first April to end of
June 2020.
ELISA kit from (Shanghai Yehua Biological Technology Company, China) was used to
measure programmed death concentration. While Real time-PCR technique (Device
Smart Cycler, USA) was used for calculating the viral load, according to Sacace
Biotechnology kit. The result was a high concentration of PD-1 in patients 295.709±29.36
and 168.337 ± 80.906) compared to healthy (106.014±63.90, 110.176 ± 36.681).
Respectively, and significant difference. and we found that PD1 concentration was
directly proportional to viral load
Conclusion: We have found that there is an enhancement in PD-1 concentration in
patients associated with healthy control groups, and We also found that PD1
concentration was directly proportional to viral load, Whenever, increased the viral load,
had risen the PD 1 concentration.